These phenotypic changes coincide with synaptic loss and tau hyperphosphorylation, hallmarks of cognitive decline in AD [124], suggesting that microglial dysfunction contributes to sustained neuroinflammation and neuronal degeneration. The gene discussed is MAPT; the disease is Alzheimer disease.